Leading science, pioneering therapies
CRM Publications

Cystic fibrosis in the mouse by targeted insertional mutagenesis.

TitleCystic fibrosis in the mouse by targeted insertional mutagenesis.
Publication TypeJournal Article
Year of Publication1992
AuthorsDorin JR, Dickinson P, Alton EW, Smith SN, Geddes DM, Stevenson BJ, Kimber WL, Fleming S, Clarke AR, Hooper ML
Date Published1992 Sep 17
KeywordsAnimals, Biological Transport, Chimera, Chlorine, Chromosome Mapping, Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Disease Models, Animal, Female, Genes, Regulator, Genotype, Male, Membrane Potentials, Membrane Proteins, Mice, Mice, Inbred Strains, Mutagenesis, Insertional

Cystic fibrosis is a fatal genetic disorder which afflicts 50,000 people worldwide. A viable animal model would be invaluable for investigating and combating this disease. The mouse cystic fibrosis transmembrane conductance regulator gene was disrupted in embryonal stem cells using an insertional gene targeting vector. Germ-line chimaeras were derived and the offspring of heterozygous crosses studied. These homozygous mutant mice survive beyond weaning. In vivo electrophysiology demonstrates the predicted defect in chloride ion transport in these mice and can distinguish between each genotype. Histological analysis detects important hallmarks of human disease pathology, including abnormalities of the colon, lung and vas deferens. This insertional mouse mutation provides a valid model system for the development and testing of therapies for cystic fibrosis patients.

Alternate JournalNature
PubMed ID1382232